Page last updated: 2024-12-10

gamma-cyclodextrin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

gamma-cyclodextrin : A cycloamylose composed of eight alpha-(1->4) linked D-glucopyranose units. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5287407
CHEMBL ID3182126
CHEBI ID495056
SCHEMBL ID8768
MeSH IDM0081435

Synonyms (60)

Synonym
bdbm36126
gamma-cyclodextrin, >=98%
gamma-cyclodextrin, powder, bioreagent, suitable for cell culture, >=98%
1P2G
einecs 241-482-4
gamma-dextrin
ringdex c
gamma-cyclodextrin
dexy pearl gamma-100
cyclooctapentylose
cyclooctaamylose
C-9140
g-cyclodextrin
17465-86-0
CHEBI:495056 ,
gamma-cd
cyclomaltooctaose
unii-kzj0byz5va
gamma cyclodextrin
ec 241-482-4
kzj0byz5va ,
gamma cyclodextrin [nf]
dtxsid5047033 ,
tox21_302303
cas-17465-86-0
NCGC00256143-01
dtxcid3027033
gamma cyclodextrin [ii]
cyclooctakis-(1->4)-(.alpha.-d-glucopyranosyl)
gamma-cyclodextrin [fcc]
cyclodextrin, gamma-
alfadex impurity b [ep impurity]
ins no.458
e-458
cavamax w8
ins-458
.gamma.-cyclodextrin
gamma cyclodextrin [usp-rs]
gamma cyclodextrin [mart.]
.gamma.-cyclodextrin [mi]
SCHEMBL8768
CHEMBL3182126
mfcd00009595
gamma-cyclodextrin, produced by wacker chemie ag, burghausen, germany, life science, 98.0-102.0% cyclodextrin basis
gamma-cyclodextrin, produced by wacker chemie ag, burghausen, germany, >=90.0% cyclodextrin basis (hplc)
gamma cyclodextrin, united states pharmacopeia (usp) reference standard
gamma-cyclodextrin, purum, >=98.0% (hplc)
gammacyclodextrin
gamma-cyclodextrin, produced by wacker chemie ag, burghausen, germany, >=98% (on dry basis)
CS-W020780
rcd
schardinger ?-dextrin
GDSRMADSINPKSL-HSEONFRVSA-N
F15410
AS-19609
Q27225754
cyclomaltooctaose, cyclooctaamylose, schardinger gamma-dextrin, gamma-cyclodextrin
gamma -cyclodextrin
AKOS037643646
HY-W040040

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"3 g/kg body wt in female dogs) was tolerated without any toxic effects."( Subchronic (13-week) oral toxicity study of gamma-cyclodextrin in dogs.
Bär, A; Til, HP, 1998
)
0.56
" The fetuses were examined for signs of toxic and teratogenic effects."( Embryotoxicity and teratogenicity study with gamma-cyclodextrin in rats.
Bär, A; Verhagen, FJ; Waalkens-Berendsen, DH, 1998
)
0.56
" It was concluded that dietary gamma-CD is well tolerated by pregnant rabbits, has no adverse effect on reproductive performance, and is not embryotoxic, fetotoxic, or teratogenic at dietary concentrations of up to 20%."( Embryotoxicity and teratogenicity study with gamma-cyclodextrin in rabbits.
Bär, A; Smits van Prooije, AE; Waalkens-Berendsen, DH, 1998
)
0.56
" On basis of these studies it is concluded that gamma-CD is generally recognized as safe (GRAS) for its intended uses in food."( Safety assessment of gamma-cyclodextrin.
Bär, A; Munro, IC; Newberne, PM; Young, VR, 2004
)
0.64

Pharmacokinetics

ExcerptReferenceRelevance
"The effects of beta- and gamma-cyclodextrins (CyDs) on the pharmacokinetic behavior of prednisolone after intravenous or intramuscular administration in rabbits were investigated."( Effects of beta- and gamma-cyclodextrins on the pharmacokinetic behavior of prednisolone after intravenous and intramuscular administrations to rabbits.
Arimori, K; Uekama, K, 1987
)
0.9
" However, the effective use of artemisinin is limited by the pharmacokinetic characteristics of the drug (low water solubility, poor bioavailability and short half-life)."( Pharmacokinetic study of intravenously administered artemisinin-loaded surface-decorated amphiphilic γ-cyclodextrin nanoparticles.
Choisnard, L; Gérard Yaméogo, JB; Gèze, A; Godin-Ribuot, D; Mazet, R; Putaux, JL; Semdé, R; Wouessidjewe, D, 2020
)
0.56

Bioavailability

ExcerptReferenceRelevance
" The potential of these alternative formulations for increasing the ocular bioavailability of forskolin is discussed."( Preparation and evaluation in rabbits of topical solutions containing forskolin.
Burgalassi, S; Giannaccini, B; Saettone, MF, 1989
)
0.28
" The enhanced rate of bioavailability of prednisolone after intramuscular administration in the form of a suspension may be due to the rapid dissolution of CyD complexes."( Effects of beta- and gamma-cyclodextrins on the pharmacokinetic behavior of prednisolone after intravenous and intramuscular administrations to rabbits.
Arimori, K; Uekama, K, 1987
)
0.59
" In spite of its poor solubility, PZQ is well absorbed across the gastrointestinal tract, but large doses are required to achieve adequate concentrations at the target sites."( Improvement of the in vitro dissolution of praziquantel by complexation with alpha-, beta- and gamma-cyclodextrins.
Becket, G; Schep, LJ; Tan, MY, 1999
)
0.52
" The three experiments taken together suggest that the complexation of fluoxetine HCl into gamma-cyclodextrin increases its pharmacological efficacy in animals, this effect being related to an enhancement of its oral bioavailability as demonstrated in human healthy subjects."( The inclusion of fluoxetine into gamma-cyclodextrin increases its bioavailability: behavioral, electrophysiological and pharmacokinetic studies.
Bruhwyler, J; Decamp, E; Dresse, A; Géczy, J; Lejeune, C; Liégeois, JF; Masset, H; Scuvée-Moreau, J; Seutin, V; Szejtli, J; Szente, L; Van Heugen, JC, 2000
)
0.81
"To explore the use of cyclodextrins (CD) to form inclusion complexes with beta-lapachone (beta-lap) to overcome solubility and bioavailability problems previously noted with this drug."( Enhancement of solubility and bioavailability of beta-lapachone using cyclodextrin inclusion complexes.
Beman, M; Boothman, DA; Bornmann, WG; Bruening, A; Gao, J; Nasongkla, N; Ray, D; Wiedmann, AF, 2003
)
0.32
" Biologic activity and bioavailability of beta-lap inclusion complexes were investigated by in vitro cytotoxicity studies with MCF-7 cells and by in vivo lethality studies with C57Blk/6 mice (18-20 g)."( Enhancement of solubility and bioavailability of beta-lapachone using cyclodextrin inclusion complexes.
Beman, M; Boothman, DA; Bornmann, WG; Bruening, A; Gao, J; Nasongkla, N; Ray, D; Wiedmann, AF, 2003
)
0.32
" An interaction of ingested gamma-CD with the absorption of fat-soluble vitamins or other lipophilic nutrients is not to be expected because the formation of inclusion complexes is a reversible process, gamma-CD is readily digested in the small intestine, and studies with beta-CD, a non-digestible cyclodextrin, have shown that the bioavailability of vitamins (A, D, and E) is not impaired."( Safety assessment of gamma-cyclodextrin.
Bär, A; Munro, IC; Newberne, PM; Young, VR, 2004
)
0.64
" Present work also suggests that properly optimized encapsulation in appropriate receptor pocket can enhance the bioavailability of drugs."( Effect of encapsulation in the anion receptor pocket of sub-domain IIA of human serum albumin on the modulation of pKa of warfarin and structurally similar acidic guests: a possible implication on biological activity.
Datta, S; Halder, M, 2014
)
0.4
"This study selected γ-cyclodextrin (γ-CD) as the inclusion material and prepared inclusion complex of taxifolin-γ-CD by the emulsion solvent evaporation and the freeze drying combination method to achieve the improvement of the solubility and oral bioavailability of taxifolin."( The high water solubility of inclusion complex of taxifolin-γ-CD prepared and characterized by the emulsion solvent evaporation and the freeze drying combination method.
Li, Y; Wu, W; Zhang, Y; Zhao, X; Zhong, C; Zu, Y, 2014
)
0.4
"According to the Biopharmaceutics Classification System, oral bioavailability of drugs is determined by their aqueous solubility and the ability of the dissolved drug molecules to permeate lipophilic biological membranes."( Evaluation of γ-cyclodextrin effect on permeation of lipophilic drugs: application of cellophane/fused octanol membrane.
Jansook, P; Loftsson, T; Muankaew, C, 2017
)
0.46
" Thus, bioavailability of γCD is negligible."( γ-Cyclodextrin.
Loftsson, T; Saokham, P, 2017
)
0.46
" In this study, we investigated the bioavailability of a new γ-cyclodextrin curcumin formulation (CW8)."( Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects.
Lowery, RP; Mannan, H; Münch, G; Purpura, M; Razmovski-Naumovski, V; Wilson, JM, 2018
)
0.48
" This study aimed to determine thermal stability and bioavailability of perilla oil that was powdered by inclusion complexation with γ-cyclodextrin."( Thermal stability and bioavailability of inclusion complexes of perilla oil with γ-cyclodextrin.
Kawahara, H; Kurata, K; Narumiya, Y; Oe, S; Shimizu, H; Yamamoto, T; Yoshikiyo, K; Yoshioka, Y, 2019
)
0.51
" However, the effective use of artemisinin is limited by the pharmacokinetic characteristics of the drug (low water solubility, poor bioavailability and short half-life)."( Pharmacokinetic study of intravenously administered artemisinin-loaded surface-decorated amphiphilic γ-cyclodextrin nanoparticles.
Choisnard, L; Gérard Yaméogo, JB; Gèze, A; Godin-Ribuot, D; Mazet, R; Putaux, JL; Semdé, R; Wouessidjewe, D, 2020
)
0.56
"Grapefruit (Citrus paradisi) juice enhances the oral bioavailability of drugs that are metabolized by intestinal cytochrome P450 3A4 (CYP3A4)."( Processing grapefruit juice with γ-cyclodextrin attenuates its inhibitory effect on cytochrome P450 3A activity.
Iohara, D; Kadowaki, D; Kawazu, S; Nishi, K; Nishizaki, N; Otagiri, M; Oyama, Y; Seo, H; Taguchi, K; Yamasaki, K, 2020
)
0.56
"To enhance the oral bioavailability of heparin, a self-nano-emulsifying drug delivery system (SNEDDS) was developed using hydrophobic ion-pairing with cationic polymers of α-, ß-, and γ-cyclodextrins (CPCDs)."( Hydrophobic ion pairing with cationic derivatives of α-, ß-, and γ-cyclodextrin as a novel approach for development of a self-nano-emulsifying drug delivery system (SNEDDS) for oral delivery of heparin.
Bahiraei, M; Derakhshandeh, K; Mahjub, R, 2021
)
0.62

Dosage Studied

ExcerptRelevanceReference
" The rate of 14C exhalation reached a maximum at 90 min after dosing and then declined steadily."( Disposition of [14C]gamma-cyclodextrin in germ-free and conventional rats.
Bär, A; De Bie, AT; Van Ommen, B, 1998
)
0.62
" In most cases where specific chemical interactions--metal coordination, "cage" compound inclusion, or pi-stacking--were expected, analyte dosing caused distinctive changes in the IR spectra, together with anomalously large SAW sensor responses."( Effective use of molecular recognition in gas sensing: results from acoustic wave and in situ FT-IR measurements.
Bodenhöfer, K; Göpel, W; Hierlemann, A; Ricco, AJ, 1999
)
0.3
" However, their short duration of action requiring multiple daily dosing can hamper patient compliance."( Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension.
Bas, JF; Jansook, P; Kristjánsdóttir, SS; Loftsson, T; Sigurdsson, BB; Sigurdsson, HH; Stefánsson, E; Thorsteinsdóttir, M, 2010
)
0.36
"A fast and selective capillary electrophoresis method has been developed for the simultaneous determination of the antihypertensive drugs captopril and hydrochlorothiazide and their related impurities in a combined dosage form."( Cyclodextrin- and solvent-modified micellar electrokinetic chromatography for the determination of captopril, hydrochlorothiazide and their impurities: A Quality by Design approach.
Brusotti, G; Caprini, C; Del Bubba, M; Furlanetto, S; Innocenti, M; Orlandini, S; Pasquini, B, 2016
)
0.43
" The results acquired for determination of phenobarbitone in its dosage forms utilizing the proposed sensors are in good agreement with those obtained by the British Pharmacopoeial method."( Ionophore-based potentiometric PVC membrane sensors for determination of phenobarbitone in pharmaceutical formulations.
Abounassif, M; Al-Majed, A; Alrabiah, H; Mostafa, GA, 2016
)
0.43
" It is known that sugammadex cannot always prevent its occurrence, if appropriate dosing is not chosen based on the level of neuromuscular paralysis prior to administration determined by objective neuromuscular monitoring."( Preparing for the unexpected: special considerations and complications after sugammadex administration.
Brull, SJ; Iwasaki, H; Kunisawa, T; Renew, JR, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (2 Product(s))

Product Categories

Product CategoryProducts
Other1
Herbs, Botanicals & Homeopathy1

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Terry Naturally HRG80 Red Ginseng Energy Chewable -- 30 Chewable TabletsTerry NaturallyHerbs, Botanicals & Homeopathygamma cyclodextrin, xylitol2024-11-29 10:47:42

Drug Classes (1)

ClassDescription
cyclodextrinA macrocycle composed of five or more D-glucopyranose units bonded via (1->4)-linkages.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Glycogen phosphorylase, muscle formOryctolagus cuniculus (rabbit)Ki7,400.00007,400.00007,400.00007,400.0000AID977610
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2003Protein science : a publication of the Protein Society, Sep, Volume: 12, Issue:9
The binding of beta- and gamma-cyclodextrins to glycogen phosphorylase b: kinetic and crystallographic studies.
AID1811Experimentally measured binding affinity data derived from PDB2003Protein science : a publication of the Protein Society, Sep, Volume: 12, Issue:9
The binding of beta- and gamma-cyclodextrins to glycogen phosphorylase b: kinetic and crystallographic studies.
AID1351281Solubility of the compound in water assessed per 100 ml2018European journal of medicinal chemistry, Jan-20, Volume: 144Polymeric bile acid sequestrants: Review of design, in vitro binding activities, and hypocholesterolemic effects.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (384)

TimeframeStudies, This Drug (%)All Drugs %
pre-199021 (5.47)18.7374
1990's45 (11.72)18.2507
2000's111 (28.91)29.6817
2010's179 (46.61)24.3611
2020's28 (7.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.07

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.07 (24.57)
Research Supply Index5.98 (2.92)
Research Growth Index5.00 (4.65)
Search Engine Demand Index64.45 (26.88)
Search Engine Supply Index2.13 (0.95)

This Compound (40.07)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (1.03%)5.53%
Reviews8 (2.06%)6.00%
Case Studies2 (0.51%)4.05%
Observational0 (0.00%)0.25%
Other375 (96.40%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]